PAAMCP
RPRX

Pacific Alternative Asset Management Company (PAAMCO)’s Repros Therapeutics Inc. RPRX Stock Holding History

Pacific Alternative Asset Management Company (PAAMCO)’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-29,444
Closed -$263K – 140
2014
Q4 		$294K Buy
+29,444
New +$251K 0.06% 88

Other funds holding RPRX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
GAI
General American Investors New York $1.69B AUM 40.94% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
DCM
Destrier Capital Management New York $144M AUM 7.28% 1-Year Est. Return

Pacific Alternative Asset Management Company (PAAMCO)'s RPRX Position: Q1 2015 in Review

Pacific Alternative Asset Management Company (PAAMCO) sold out of Repros Therapeutics Inc. (RPRX) in Q1 2015, closing a stake of 29,444 shares — an estimated $263K sold.

Pacific Alternative Asset Management Company (PAAMCO) first reported a position in RPRX in Q4 2014 and held it in 1 quarter. The position peaked at $294K in Q4 2014. 72 funds tracked by Wall St. Rank hold RPRX as of Q1 2015.

  • Pacific Alternative Asset Management Company (PAAMCO) reported no remaining Repros Therapeutics Inc. position as of Q1 2015 after selling out during the quarter.
  • Pacific Alternative Asset Management Company (PAAMCO) sold 29,444 Repros Therapeutics Inc. shares in Q1 2015, an estimated $263K.
  • Pacific Alternative Asset Management Company (PAAMCO) first reported a position in Repros Therapeutics Inc. in Q4 2014 and held it in 1 quarter.
  • Pacific Alternative Asset Management Company (PAAMCO)'s Repros Therapeutics Inc. position peaked at $294K in Q4 2014.
  • 72 funds tracked by Wall St. Rank held Repros Therapeutics Inc. as of Q1 2015.

Based on Pacific Alternative Asset Management Company (PAAMCO)'s 13F filing for Q1 2015, filed 15 May 2015.